ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $705,992 | -16.5% | 64,474 | +0.9% | 0.00% | – |
| Q2 2023 | $845,931 | +6.9% | 63,892 | +9.9% | 0.00% | – |
| Q1 2023 | $791,081 | -31.4% | 58,125 | -1.6% | 0.00% | – |
| Q4 2022 | $1,153,539 | +5.2% | 59,065 | +2.6% | 0.00% | – |
| Q3 2022 | $1,097,000 | +9.2% | 57,554 | +18.0% | 0.00% | – |
| Q2 2022 | $1,005,000 | -31.4% | 48,790 | +7.3% | 0.00% | – |
| Q1 2022 | $1,464,000 | +488.0% | 45,470 | +752.6% | 0.00% | – |
| Q4 2021 | $249,000 | +465.9% | 5,333 | +228.6% | 0.00% | – |
| Q3 2021 | $44,000 | +4.8% | 1,623 | 0.0% | 0.00% | – |
| Q2 2021 | $42,000 | -55.3% | 1,623 | -40.4% | 0.00% | – |
| Q1 2021 | $94,000 | +135.0% | 2,723 | +128.2% | 0.00% | – |
| Q4 2020 | $40,000 | +37.9% | 1,193 | 0.0% | 0.00% | – |
| Q3 2020 | $29,000 | – | 1,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
| Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
| 683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
| Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
| DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |